06/05/2025
6:27 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
5:13 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:46 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
3:37 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/22/2025
4:27 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/14/2025
7:21 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:30 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
12:44 PM | Gyre Therapeutics (Filer)
| Form ARS | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for GYRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/20/2025
3:01 PM | Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/17/2025
3:15 PM | Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2025
7:00 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:02 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:01 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
7:45 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:05 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:06 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Gyre Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:05 PM | Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
7:45 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
7:31 AM | Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
| Form SC 13D | |
09/06/2024
7:15 AM | Gyre Therapeutics (Subject)
Luo Ying (Filed by)
| Form SC 13D | |
08/16/2024
8:13 PM | Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:53 PM | Chen Ruoyu (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:56 PM | Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:58 PM | Eastling Thomas Wilson (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:05 PM | Carmichael Gordon (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:07 PM | Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
5 Stocks That Could Double Your Investment in 2025 (Ad) 5 Stocks That Could Double in 2025 🚀
Our analysts have identified five stocks with the potential to double in 2025. From a company poised to lead the crypto ETF market to an innovator in fuel cell technology for AI and data centers, these picks could be game-changers for your portfolio. Don’t miss these insights. |
08/16/2024
8:10 PM | Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:50 PM | Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:04 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:31 PM | Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
3:27 PM | Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free GYRE Stock Alerts